Medication info
Telmis Plus Tablet 40/12.5 mg

Telmis Plus Tablet 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Samil Pharmaceutical Co., Ltd.
Appearance
White or nearly white, oval tablets with a convex surface on both sides
Packaging
10 tablets/blister X 3, 100 tablets/bottle
Approval status
Active

MFDS item code 201001022 · Notified 2010.01.29 · Insurance code 643902830

Summary

Main use
Treats essential hypertension inadequately controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide 40/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide 80/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide 80/25mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dosage adjustment is required.
Child dose
Children under 18 years of age: The safety and efficacy of this medicine have not been established.

Ingredients

Manufacturer
Samil Pharmaceutical Co., Ltd.

Efficacy & effects

Treats essential hypertension inadequately controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used when blood pressure control is insufficient with Telmisartan alone in patients with essential hypertension. That is, it helps to effectively lower and control blood pressure, contributing to a reduction in cardiovascular risk.

How to take

Adult dose

Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this medicine may also be considered. - The telmisartan/hydrochlorothiazide 40/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide 80/12.5mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide 80/25mg combination may be given to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this medicine. Patients with renal impairment No dosage adjustment is required in patients with mild to moderate renal impairment. Do not administer this medicine to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This medicine should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this medicine per day. Do not administer this medicine to patients with severe hepatic impairment (see Precautions for Use, section 2). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dosage adjustment is required.

Child dose

Children under 18 years of age: The safety and efficacy of this medicine have not been established.

Precautions

This medication should not be used during pregnancy, especially in the second and third trimesters, as it can cause serious harm to the fetus. If pregnancy is confirmed, this medication should be discontinued immediately. Patients with allergies to any of the components in this medication or those with certain liver or kidney diseases should not use it. Elderly patients or those with issues concerning potassium levels should use this medication cautiously and require regular blood tests. Hydrochlorothiazide may cause electrolyte imbalances in the body; therefore, dehydration or symptoms of electrolyte abnormalities should be monitored during use. This medication may interact with other antihypertensive drugs, diuretics, potassium supplements, etc., so it is essential to consult a physician when taking it in combination with other medications. Caution is needed while driving or operating machinery as symptoms such as dizziness or drowsiness may occur. Due to the possibility of increased risk of skin cancer, it is important to avoid sun exposure and regularly check skin conditions. In cases of overdose, symptoms like hypotension, electrolyte abnormalities, and dehydration may appear; immediate medical attention is required. This medication is not recommended for children as safety has not been established, and it should be stored out of reach of children.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 191 more
  • dizziness
  • syncope
  • paresthesia
  • visual disturbances
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • hepatic disease
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased serum creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • coughing
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • weakness
  • influenza-like illness
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal dysfunction
  • weakness
  • fever
  • nausea
  • abdominal pain
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremors
  • facial flushing
  • malaise
  • fatigue
  • anxiety
  • proteinuria
  • rash
  • itching
  • myalgia
  • a feeling of unreality
  • lip and hand tremors
  • sensory hypersensitivity
  • visual impairment
  • hypotension
  • tachycardia
  • bradycardia
  • orthostatic hypotension
  • dyspnea
  • coughing
  • acute respiratory distress syndrome
  • pancreatitis
  • angioedema
  • angioedema
  • thrombocytopenia
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • anaphylactic reaction
  • hypokalemia
  • hyperlipidemia
  • hyponatremia
  • hyperuricemia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic metabolic alkalosis
  • depression
  • sleep disorders
  • dizziness
  • paresthesia
  • headache
  • visual disturbances
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal effusion
  • arrhythmia
  • orthostatic hypotension
  • necrotizing vasculitis
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • nausea
  • vomiting
  • constipation
  • abdominal discomfort
  • pancreatitis
  • jaundice
  • cholestasis
  • rash
  • urticaria
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • muscle spasms
  • acute renal failure
  • diabetes
  • renal dysfunction
  • erectile dysfunction
  • weakness
  • fever
  • dizziness
  • diarrhea
  • coughing
  • nausea
  • headache
  • gastrointestinal bleeding
  • esophagitis
  • fatigue
  • weight loss
  • proteinuria
  • itching
  • myalgia
  • a feeling of unreality
  • dry lips
  • hypoglycemia
  • angioedema
  • intestinal angioedema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. It is important to maintain the storage temperature between 1 to 30 degrees Celsius for optimal effectiveness.

Appearance and packaging

Appearance

White or nearly white, oval tablets with a convex surface on both sides

Package unit

10 tablets/blister X 3, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.